BKT Targets ~10% US Volume, Stops Guidance Amid Volatility

Balkrishna Industries Limited (BKT) — Q4 & FY26 Earnings Call (May 9, 2026)

1. Overall Tone of Management: Neutral

• Management is confident on medium/long-term (“remain confident in our ability to deliver sustainable and profitable growth over the medium to long term”) and highlights operational wins (highest quarterly/annual volumes in FY26).
• However, the tone is tempered by repeated near-term caution: “macro uncertainties persist”, raw material upticks, and explicit margin pressure risk (“we may have some price pressures, margin pressures”).
• They also avoid quantitative guidance due to volatility (“we stopped giving guidance due to the geopolitical scenarios and uncertainties”).

2. Key Themes from Management Commentary

• Resilience + volume recovery in H2
• “continued sequential improvements in volumes”
• “H2 performance was significantly better than H1”
• “highest ever quarterly volumes in Q4” and “highest ever volumes annually in FY 2026”
• Geography-specific demand signals
• Europe: recovery attributed to “easing of channel inventories”
• Americas: “improving traction supported by higher channel activity”; sharper go-to-market focus
• India: sustained momentum; “cautiously optimistic… given the weather forecast of IMD for the upcoming monsoon season”
• Cost/margin management under input volatility
• Raw material price upticks from supply chain disruptions; balancing “superior product mix and price hikes”
• Freight expected to rise only marginally (subject to no further disruption)
• Capex execution + capacity ramp
• Carbon black: new line commissioned (capacity to 265,000 MTPA), full utilization for new lines; balance capacity targeted Q1 FY27
• On-highway: CV radial launched (Feb 2026), 2-wheeler relaunch; PCR planned by end of calendar year
• Additional capex approved: INR 2,000 crores (AI-enabled automation + sustainability + capacity/infrastructure)
• Strategic narrative: sustained EBITDA discipline
• Repeated emphasis on maintaining company-level EBITDA 23%–25% despite scaling on-highway.

3. Q&A Analysis

Theme A: US tariff / volume share / pricing pass-through

• Core questions
• FY26 US volume contribution and whether it returns to ~10% in FY27.
• Tariff refund process (who receives it) and filed quantum.
• Commodity basket impact, price hikes taken, and freight as % of revenue.
• Management responses
• US volume: “just short of 10%, but close”; “That is our ambition… targeting for the year” (FY27).
• Price hikes: “between 3% to 5% already”; targeting “around 2% in this very month”; may take more.
• Raw material price impact: Q4 “approximately 4%, 5%”; Q1 expectation “7% to 8% more”.
• Freight: Q4 “about 4.5% to 5%”; expect marginal increase.
• Tariff refund: filed as importer on record; “as of now, we have not received anything”; fair practice to pass back part recovered from customers (no exact quantum provided).
• Notable / evasive elements
• No quantitative refund amount (“not handy with the number”).
• No guidance on volumes beyond “expecting growth” due to volatility.

Theme B: Guidance, demand outlook, and margin trajectory

• Core questions
• Whether they can provide OHT volume guidance for FY27.
• Near-term margin pressure from raw material costs and whether price hikes fully offset.
• Whether TBR revenue starts in Q4/Q1 and Europe growth expectations.
• Management responses
• Guidance: “So we stopped giving guidance due to the geopolitical scenarios and uncertainties.”
• Margin: explicitly acknowledged near-term pressure: “at this moment, we may have some price pressures, margin pressures.”
• TBR revenue timing: “very insignificant in the first quarter, but thereafter… gaining prominence.”
• Europe: declined to quantify; “too volatile to give any guidance”; geared to support market share when available.
• Notable / unusually strong
• Despite acknowledging margin pressure, they still defend sustained EBITDA 23%–25% at company level.

Theme C: Capex plan details, phasing, and funding

• Core questions
• FY27 total capex given additional INR2,000 crores.
• Where incremental capex goes (capacity vs productivity).
• Whether INR6,800 crores includes already spent amounts; project vs maintenance.
• Capex phasing across FY27–FY29 and maintenance run-rate.
• Funding source and debt peak assumptions.
• Management responses
• FY27 capex: “between INR1,500 crores to INR1,800 crores.”
• Incremental INR2,000 crores: capacity expansion + infrastructure + “AI-enabled automation… and sustainability initiatives”; productivity/cost efficiency intent confirmed.
• INR6,800 crores: includes already spent; “around INR3,000 crores” spent; remaining “INR3,800 crores.”
• Maintenance: “about INR200-odd crores every year” (extra).
• Funding: “mix of both… yet working on it”; refused to assume debt peak (“It’s a volatile world…”).
• Notable / evasive
• No clear funding mix (equity/debt/cash) and no debt trajectory.

Theme D: On-highway strategy, distribution readiness, and product positioning

• Core questions
• Qualitative scaling plan for on-highway; peak revenue expectations by segment.
• Distributor count and dealership ramp.
• PCR positioning (premium vs discounting) and price parity.
• Value proposition vs competitors (retail pricing advantage).
• Outsourcing/scale-up constraints.
• Management responses
• Vision: INR5,000 crores revenue by 2030; distribution primary distributors “nearly complete”; “about 90 in all”.
• Margins: reiterated company-level EBITDA 23%–25% and “sustained EBITDA levels”.
• PCR positioning: “not discounting… in line with the market leaders.”
• Pricing/value: “price positioning is at par with the market leaders”; route to entry is “product quality and… operations excellence.”
• Outsourcing: “At the moment, we don’t see it as a limiting factor.”
• Capacity for 2-wheeler: “about 100,000 tyres a month”; ramps with market response.
• Notable / evasive
• No peak revenue numbers by TBR/PCR/2W.
• No explicit market share targets for FY27.

Theme E: Carbon black economics and specialty ramp

• Core questions
• Captive vs external split; carbon black revenue/EBITDA margin.
• Specialty carbon black utilization and when it ramps.
• Management responses
• Captive/external: “30%… consuming locally… around 70% is sold in the market.”
• Margins: “margins are as per industry average.”
• Specialty approvals secured; ramp timing implied via capacity coming on stream Q1 FY27 and specialty improving “in the coming quarters.”
• Notable
• They avoid giving specialty margin upside; keep it “industry average.”

Theme F: FX hedging / realization

• Core questions
• EUR/INR realization in Q4 and hedge rate for FY27.
• Management responses
• Q4 EUR realization: “~INR99 for this quarter for euro.”
• FY27 hedge: “It will be higher than this year… but it is not full year” (can’t comment fully).
• Notable / evasive
• No full-year hedge rate disclosure.

4. Guidance / Outlook

Explicit guidance (quantitative)

• Capex
• Additional capex approved: INR 2,000 crores
• FY27 capex: INR 1,500–1,800 crores
• Maintenance capex: ~INR 200-odd crores/year (extra)
• Total capex framework: INR 6,800 crores till FY29 (includes ~INR3,000 crores already spent; ~INR3,800 crores remaining)
• Carbon black
• New line utilization: “full utilization levels”
• Balance carbon black capacity targeted: Q1 FY27
• Price actions / cost
• Price hikes taken: 3%–5% already; targeting ~2% in the current month
• Raw material price pressure expectation: Q1 +7% to +8% (basket)
• Freight: Q4 4.5%–5%; expected marginal increase
• Segment timing
• TBR revenue: “very insignificant in the first quarter, but thereafter…”
• PCR capacity start: end of calendar year; first phase ~6,700 tyres/day
• TBR Phase 1 capacity: 800 tyres/day, ramp to ~3,800 tyres/day
• US share
• US volume ambition: “just short of 10%…” in FY26; targeting back to ~10% in FY27

Implicit signals (qualitative)

• No volume guidance due to geopolitical uncertainty; “expecting growth” but not quantified.
• Margin risk acknowledged: “may have some price pressures, margin pressures” near term.
• Demand normalization in Europe/Americas tied to channel inventory easing and higher channel activity.
• Product mix strategy: shift toward “high-end radialized products… IF/VF technology products” to support margins.
• Distribution readiness: primary distributors “nearly complete”; dealerships ramp with sales.

5. Standout Statements (direct / high-signal)

• On guidance
• “So we stopped giving guidance due to the geopolitical scenarios and uncertainties.”
• On near-term margins
• “at this moment, we may have some price pressures, margin pressures.”
• On performance
• “highest ever quarterly volumes in Q4” and “highest ever volumes annually in FY 2026”
• On Europe recovery driver
• “driven by easing of channel inventories”
• On US
• “That is our ambition… targeting for the year” (return to ~10% volume share)
• On capex intent
• INR2,000 crores is for “capacity expansion and infrastructure development… AI-enabled automation… and sustainability initiatives”
• On EBITDA discipline
• “we are… looking to keep sustained EBITDA levels…” and “company as a whole… maintaining… 23% to 25%”
• On PCR positioning
• “we are not discounting our products… in line with the market leaders”
• On carbon black economics
• “margins are as per industry average” (no specialty margin premium promised)

6. Red Flags / Positive Signals

Red flags
– No quantitative outlook (volumes, Europe growth, margins) while cost pressures are explicitly rising.
– Margin pressure acknowledged (raw material basket +7% to +8% in Q1) without clear confirmation that price hikes will fully offset.
– Hedging transparency limited: FY27 hedge rate not fully disclosed (“not full year… unable to comment”).
– Tariff refund quantum not provided; reliance on “fair practice” pass-through without numbers.

Positive signals
– Operational execution credibility: carbon black new line commissioned and “full utilization levels”.
– Demand normalization evidence: Europe H2 recovery tied to inventory easing; Americas traction improving.
– Capex execution confidence: “expected to be completed as per schedule” for key projects.
– Distribution build-out progressing: primary distributors nearly complete; dealerships ramp with sales.

7. Historical Comparison & Consistency Analysis

a. Change in Tone Over Time

• Earlier calls (May 24, 2025 / Jul 28, 2025 / Nov 1, 2025 / Jan 29, 2026):
• More emphasis on confidence in plans and sometimes margin guidance (e.g., May 2025: blended margins 23%–25% steady; Jul 2025: strive 24%–25%; Nov 2025: guidance around 24%–25%).
• Still cautious, but management often framed headwinds as manageable and sometimes discussed expected normalization timelines.
• Current call (May 9, 2026):
• Tone is more cautious on near-term: explicitly says margin pressures may occur and stopped giving guidance.
• Classification shift: More cautious / Neutral vs prior periods that were relatively more “guidance-oriented.”
• Key change: stronger admission of near-term margin pressure and reduced willingness to quantify outlook.

b. Tracking Past Commitments vs Outcomes

• Carbon black specialty ramp
• Past: Nov 1, 2025 said specialty approvals and “Next financial year, we should able to see” ramp; May 24, 2025: advanced carbon black line “started… trials…”
• Current: specialty approvals secured; balance carbon black capacity targeted Q1 FY27; specialty ramp implied “coming quarters.”
• Assessment: ⏳ Delayed / still in ramp (no clear specialty revenue/margin delivered yet; still “approvals” and “improve in coming quarters”).
• CV radial / TBR ramp timing
• Past: May 24, 2025: CV radial pilot in Q4 FY25/26 and gradual ramp; Nov 1, 2025: “pilot… slow start… second half of next fiscal”
• Current: CV radial launched Feb 2026; TBR revenue “very insignificant in the first quarter, but thereafter…”
• Assessment: ✅ Broadly on track (timing language remains consistent: ramp is gradual; early impact small).
• Guidance behavior
• Past: Nov 1, 2025 and Jul 28, 2025 included margin guidance ranges.
• Current: “stopped giving guidance” on volumes; still defends EBITDA range but with less forward quantification.
• Assessment: ⏳ Reduced guidance transparency (not necessarily missed performance, but less commitment on forward numbers).

c. Narrative Shifts

• From “tariff normalization will drive momentum quickly” → “too volatile to guide”
• Earlier: Nov 1, 2025 suggested US normalization “within a couple of weeks” once easing starts.
• Current: no volume guidance; only “ambition” to return US share.
• On margins:
• Earlier: more confident about maintaining EBITDA range with offsets.
• Current: explicitly expects near-term margin pressure due to raw material uptick and only partial mitigation via price hikes/product mix.
• On carbon black:
• Earlier: specialty ramp and utilization expectations were more forward-looking.
• Current: carbon black is operationally strong (utilization), but specialty economics remain “industry average” and ramp is still staged.

d. Consistency & Credibility Signals

• Medium credibility
• Strength: capex execution claims (commissioning, utilization) appear concrete.
• Weakness: repeated refusal to quantify (guidance, tariff refund quantum, hedge rates) and margin pressure admissions without clear mitigation proof.
• Pattern: operational wins are emphasized, while forward-looking quantification is constrained.

e. Evolution of Key Themes

• Demand / channel inventory: improving narrative in Europe (H2 recovery) is consistent with prior “destocking leveling out” explanations.
• Margins: shift from “guidance ranges” to “sustained EBITDA endeavor” + explicit near-term pressure.
• Expansion strategy: remains consistent—OHT diversification + carbon black capacity + new Indian categories (CV/TBR, 2W, PCR).
• Risk framing: geopolitical volatility increasingly used to justify lack of guidance.

f. Additional Insights (cross-period intelligence)

• The company’s margin defense increasingly relies on product mix and price hikes, but management simultaneously discloses raw material basket pressure rising into Q1—suggesting the margin cushion may be thinner than earlier implied.
• Carbon black is now a stabilizer operationally (utilization, capacity), but specialty carbon black still lacks a clear “delivered” revenue/margin contribution—implying the specialty upside may be later-cycle rather than near-term.